BVS
Bioventus Inc.
NASDAQ · Healthcare · Medical - Devices · US
$12.91
+2.22%Forward multiples
Based on analyst estimates
- P/E forward
- 16.65x
- P/E 2026E
- 16.50x
- P/E 2027E
- 13.96x
- P/E 2028E
- 12.10x
- P/S forward
- 1.42x
Trailing multiples
Trailing twelve months
- P/E TTM
- 16.07x
- PEG TTM
- —
- Price / book
- 3.86x
- Price / sales
- 1.52x
- Price / cash flow
- 9.10x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 2.00x
- EV / EBITDA
- 12.55x
- EV / EBIT
- 18.84x
- Market cap
- $881.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026